assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_007858495.1_ASM785849v1	NZ_CP041663	Mycoplasma anserisalpingitidis strain MYCAV93 chromosome, complete genome	1	826674-827237	1,1,1	CRISPRCasFinder,CRT,PILER-CR	no	cas1,cas2,csn2,cas9	DEDDh,cas1,cas2,csn2,cas9	Type II-C,Type II-B,Type II-A	GTTTTTTGGTTGTGTTAAAGTTGAGTTAGTATA,GTTTTTTGGTTGTGTTAAAGTTGAGTTAGTATAGAC,TTTTTTGGTTGTGTTAAAGTTGAGTTAGTATAGAC	33,36,35	0	0	NA	NA	NA:NA:NA	8,8,7	8	TypeII-C,TypeII-B,TypeII-A	DEDDh,cas1,cas2,csn2,cas9	NA|233aa|up_9|NZ_CP041663.1_811713_812412_+,NA|253aa|up_8|NZ_CP041663.1_812517_813276_+,csn2|250aa|up_0|NZ_CP041663.1_825883_826633_+,NA|203aa|down_2|NZ_CP041663.1_832885_833494_-,NA|241aa|down_3|NZ_CP041663.1_833575_834298_-,NA|285aa|down_4|NZ_CP041663.1_834720_835575_+,NA|309aa|down_5|NZ_CP041663.1_836157_837084_+,NA|119aa|down_6|NZ_CP041663.1_837389_837746_+,NA|252aa|down_9|NZ_CP041663.1_841227_841983_-	NA|233aa|up_9|NZ_CP041663.1_811713_812412_+	NA	NA|253aa|up_8|NZ_CP041663.1_812517_813276_+	NA	NA|356aa|up_7|NZ_CP041663.1_813382_814450_+	pfam00004, AAA, ATPase family associated with various cellular activities (AAA)	NA|753aa|up_6|NZ_CP041663.1_814433_816692_+	cd04847, Peptidases_S8_Subtilisin_like_2, Peptidase S8 family domain in Subtilisin-like proteins	NA|526aa|up_5|NZ_CP041663.1_816851_818429_+	TIGR00497, hsdM, type I restriction system adenine methylase (hsdM)	NA|394aa|up_4|NZ_CP041663.1_819027_820209_+	cd17269, RMtype1_S_PluTORF4319P-TRD2-CR2_like, Type I restriction-modification system specificity (S) subunit Target Recognition Domain-ConseRved domain (TRD-CR), similar to Photorhabdus luminescens S subunit (S	NA|1018aa|up_3|NZ_CP041663.1_820222_823276_+	COG0610, COG0610, Type I site-specific restriction-modification system, R (restriction) subunit and related helicases [Defense mechanisms]	cas1|297aa|up_2|NZ_CP041663.1_824703_825594_+	cd09720, Cas1_II, CRISPR/Cas system-associated protein Cas1	cas2|103aa|up_1|NZ_CP041663.1_825575_825884_+	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	csn2|250aa|up_0|NZ_CP041663.1_825883_826633_+	NA	cas9|1346aa|down_0|NZ_CP041663.1_827346_831384_-	cd09643, Csn1, CRISPR/Cas system-associated protein Cas9	NA|298aa|down_1|NZ_CP041663.1_831885_832779_-	pfam08843, AbiEii, Nucleotidyl transferase AbiEii toxin, Type IV TA system	NA|203aa|down_2|NZ_CP041663.1_832885_833494_-	NA	NA|241aa|down_3|NZ_CP041663.1_833575_834298_-	NA	NA|285aa|down_4|NZ_CP041663.1_834720_835575_+	NA	NA|309aa|down_5|NZ_CP041663.1_836157_837084_+	NA	NA|119aa|down_6|NZ_CP041663.1_837389_837746_+	NA	NA|435aa|down_7|NZ_CP041663.1_838654_839959_+	COG1373, COG1373, Predicted ATPase (AAA+ superfamily) [General function prediction only]	NA|367aa|down_8|NZ_CP041663.1_840118_841219_-	PRK09601, PRK09601, redox-regulated ATPase YchF	NA|252aa|down_9|NZ_CP041663.1_841227_841983_-	NA
